Form 4 for BNTC Benitec Biopharma Inc.

Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0000899140-25-000486 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2025-04-02	2025-03-31	BNTC	SUVRETTA CAPITAL MANAGEMENT, LLC	Dir, 10%	P - Purchase	$12.83	+16.5K	1.07M	+2%	+$211.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock, par value $0.0001 per share	2025-03-31	P	A	5,057	$13.22	8,807,805	I See footnotes	—	—	(F4) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
2	Common	Common stock, par value $0.0001 per share	2025-03-31	P	A	670	$13.22	1,068,701	I See footnotes	—	—	(F5) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
3	Common	Common stock, par value $0.0001 per share	2025-03-31	P	A	9,503	$12.63	8,802,748	I See footnotes	—	—	(F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.
4	Common	Common stock, par value $0.0001 per share	2025-03-31	P	A	1,267	$12.63	1,068,031	I See footnotes	—	—	(F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1.